Poster Abstract Session:
240. Stewardship: Impact of Diagnostics
Saturday, October 7, 2017: 12:30 PM-2:00 PM
Room: Poster Hall CD

Tracks: Adult ID, Epidemiology and Infection Control, Investigative ID, Pediatric ID, Trainee

Gram-Negative Polymicrobial Bloodstream Infections and Clinical Decision Making with a Microarray Testing System
Kimberly Claeys, PharmD, BCPS; Jason Pogue, PharmD; Paul Lephart, PhD; Emily Heil, PharmD, BCPS-AQID; J. Kristie Johnson, PhD
Rapid Direct Disc Diffusion Tests (RDDDT) Direct From Blood Cultures (BSI) with Gram Negative Bacilli (GNB) Coupled with Prompt Intervention is an Effective and Safe Antibiotics Stewardship Strategy
Wint Thu Hun, MD; Sara Sirajuddin, MD; Hiroki Saito, MD, MPH; Kaye D. Evans, BA/MT; Cassiana Bittencourt, MD; Ellena M. Peterson, PhD; Steven Park, MD, PhD; Lauri Thrupp, MD, FIDSA, FSHEA
Clinical Impact of Expedited Pathogen Identification and Susceptibility Testing for Gram-negative Bacteremia and Candidemia Using the Accelerate PhenoTM System
Jason Burnham, MD; Meghan Wallace, BS; Brian Fuller, MD, MSCI; Carey-Ann D. Burnham, PhD; Marin Kollef, MD, FACP, FCCP
  • AXDX.IDweek.2017.clinical.pdf (247.2 kB)
  • Validation of an Antimicrobial Stewardship Driven Verigene® Blood-Culture Gram-Negative Treatment Algorithm to Improve Appropriateness of Antibiotics 
    Kathryn Schlaffer, MD; Emily Heil, PharmD, BCPS; Surbhi Leekha, MBBS, MPH; J. Kristie Johnson, PhD; Kimberly Claeys, PharmD, BCPS
    Rapid Identification of Gram-Negative Bacteremia and Impact on Anti-Pseudomonal Antibiotic Consumption in Combination with Antibiotic Stewardship at a Community-Based Hospital System
    Maggie Box, PharmD, BCPS, AQ-ID; Jennifer Lee, PharmD; Kristine Ortwine, MS, MPH; Caitlin Richardson, PharmD, BCPS; Eva Sullivan, PharmD; Samantha Wong, PharmD
  • Slide1.JPG (2.9 MB)
  • Rapid Multiplex Gastrointestinal Pathogen Panel Testing Improves Antibiotic Stewardship in Patients with Suspected Infectious Diarrhea Compared to Conventional Methods
    Norman Beatty, MD; David Nix, PharmD; Jessica August, MD; Roberto Swazo, MD; Kyle Mckeown, MPH; Mohannad Alshibani, PharmD; Wanda Petty, BS; Kathryn Matthias, PharmD; Mayar Al Mohajer, MD, MBA, CAQ, FACP
    Implementation of Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) and Antimicrobial Stewardship Intervention at an Academic Medical Center
    Sarah Elhalis, PharmD; John Macko, PharmD, MBA; Heather Byrd, MLS (ASCP) CM; Joan Duggan, MD, FIDSA, FACP; Claudiu Georgescu, MD; Kelli Cole, PharmD, BCPS
    Impact of Verigene Multiplex PCR for Positive Blood Cultures and Gram Negative Bacteremia
    Matthew Adams, DO; David Nix, PharmD; Kathryn Matthias, PharmD; Abdulhmid Althaghfi, PharmD; Mimi Bach, MD; Mayar Al Mohajer, MD, MBA, CAQ, FACP
  • verigene_adams1.pdf (190.2 kB)
  • Impact of a Rapid Diagnostic for Bloodstream Infections with Antimicrobial Stewardship Intervention at a Comprehensive Cancer Center
    Brian Buss, PharmD; Timothy Baures, MD; Minkyoung Yoo, PhD; Kim Hanson, MD, MHS; Donald Alexander, PharmD; Russell Benefield, Pharm.D., BCPS (AQ-ID); Emily Spivak, MD, MHS
  • (173.1 kB)
  • Direct Disk Diffusion Susceptibility Testing for Staphylococcus aureus from Blood Cultures: Diagnostic Accuracy and Impact on Antimicrobial Stewardship
    Michael Payne, MD, FRCPC; Christopher F. Lowe, MD, FRCPC; Victor Leung, MD, FRCPC; Marc G. Romney, MD, FRCPC; Sylvie Champagne, MD, FRCPC
    MALDI-TOF MS in adult inpatients with bloodstream infections: pre-and post-intervention study
    Salman Khan, MD; Dallas Dunn, MD; Gargi Patel, PharmD; Patricia Saunders-Hao, PharmD, BCPS; Meenakshi Rana, MD; Gopi Patel, MD, MS; Camille Hamula, PhD
    Successful Implementation of BCID across large healthcare system using a central testing laboratory and multidisciplinary pharmacy team.
    Monica Schmidt, MPH, PhD; Lisa Davidson, MD; Kelly Goodson, PharmD; Gerald A. Capraro, PhD; Lewis McCurdy, MD
  • BCID Poster FINAL.pdf (216.7 kB)
  • Evaluation of the Clinical Impact of the Biofire Filmarray® Rapid Multiplex PCR Assay in Blood Culture Identification Combined with Antimicrobial Stewardship Intervention
    Gabriela M. Andujar-Vazquez, MD; Bradley Gardiner, MBBS; Francis Magro, MD; Kirthana R. Beaulac, PharmD; Shira Doron, MD, MS, FIDSA; David R Snydman, MD
    Clinical Utility of Universal PCR and its Real-world Impact on Patient Management
    Tinzar Basein, MD; Bradley Gardiner, MBBS; Gabriela M. Andujar-Vazquez, MD; Andrew Stevenson Joel Chandranesan, MD; Arthur Rabson, MD; Shira Doron, MD, MS, FIDSA; David R Snydman, MD
    Impact of Accelerate Pheno System on Time to Antimicrobial Stewardship Intervention in Patients with Gram-Negative Blood Stream Infections
    Gerald Elliott, PharmD, BCPS; Michael Postelnick, RPh BCPS AQ ID; David Martin, PharmD, BCPS; Viktorija Barr, PharmD, BCPS-AQ-ID; Michael Malczynski, BS; Doaa Aljefri, PharmD, MSc; Sarah Sutton, MD; Teresa Zembower, MD, MPH, FIDSA; Chao Qi, PhD
    Direct Disk Diffusion Susceptibility Testing for Gram Negative Bacteria from Blood Cultures: Diagnostic Accuracy and Impact on Antimicrobial Stewardship
    Michael Payne, MD, FRCPC; Christopher F. Lowe, MD, FRCPC; Victor Leung, MD, FRCPC; Marc G. Romney, MD, FRCPC; Sylvie Champagne, MD, FRCPC
    Influence of T2Candida testing for rapid diagnosis of Candida infections on antifungal stewardship efforts at a large academic medical center: a retrospective, single-center study
    Justin F Hayes, MD; Orlando D Turner, MD; Todd P McCarty, MD; Malia Manning, RPH; Craig J Hoesley, MD; Peter G Pappas, MD
  • Poster2137_IDWeek.pdf (121.2 kB)
  • Effect of Rapid Molecular Diagnostic Testing and Antimicrobial Stewardship on Antimicrobial Therapy of Respiratory Infections
    Thomas M. File Jr., MD; Paula Politis, PharmD, BCPS; Michael J. Tan, MD, FACP, FIDSA; George Kallstrom, PhD
    Impact of PBP2a Assay on Antibiotic Therapy of Patients with Non-Blood, Non-Urine Staphylococcus aureus Infections
    Stephanie Shulder, PharmD; Victoria Adams-Sommer, PharmD; Sara E. Cosgrove, MD, MS; Kathryn Dzintars, PharmD; Patricia Simner, PhD, D,(ABMM); Pranita Tamma, MD, MHS; Edina Avdic, MBA, PharmD, BCPS AQ-ID
  • S.Shulder ID Week_PBP2a.pdf (605.0 kB)
  • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.